4.5 Article

Development of multiple biomarker panels for prediction of sarcopenia in community-dwelling older adults

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Multi-biomarker panel prediction model for diagnosis of pancreatic cancer

Doo-Ho Lee et al.

Summary: This study developed a prediction model using a multi-marker panel as a diagnostic screening tool for pancreatic ductal adenocarcinoma and demonstrated its significant diagnostic performance in distinguishing pancreatic ductal adenocarcinoma from normal and benign pancreatic disease states, as well as patients with other cancers.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

Performance of a multi-biomarker panel for prediction of cardiovascular event in patients with chronic kidney disease

Reza Mohebi et al.

Summary: Patients with CKD undergoing coronary catheterization are at increased risk of cardiovascular events. Measuring biomarkers before the procedure can help identify patients at higher risk. A prognostic algorithm incorporating 4 biomarkers showed good predictive performance for cardiovascular events within 2 years.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Review Endocrinology & Metabolism

The elusive role of myostatin signaling for muscle regeneration and maintenance of muscle and bone homeostasis

Akash Mitra et al.

Summary: Skeletal muscle is an important component of the musculo-skeletal system, contributing to stability and mobility. However, improper functioning of skeletal muscles can lead to diseases such as sarcopenia, muscular dystrophies, and cachexia. On the other hand, skeletal muscles have the ability to undergo hypertrophy and enhanced functioning through exercise. This review focuses on the role and regulation of myostatin in muscle regeneration and molecular functions.

OSTEOPOROSIS AND SARCOPENIA (2023)

Review Endocrinology & Metabolism

Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Academique de Recherche et d'Experimentation en Sante (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging

Aurelie Ladang et al.

Summary: Biochemical markers in clinical trials provide useful information on drug's mode of action, therapeutic response, and side effect monitoring. Identifying biomarkers for sarcopenia management is urgently needed for future clinical practice. A consensus paper from a working group of the ESCEO proposed a list of biochemical markers for musculoskeletal health and aging in Phase II and III clinical trials for sarcopenia treatment, and suggested classifying them into two series based on their evaluation of musculoskeletal status and causal factors.

CALCIFIED TISSUE INTERNATIONAL (2023)

Review Cell Biology

GDF15, an emerging key player in human aging

Maria Conte et al.

Summary: GDF15 is a stress-related cytokine that plays an important role in the aging process. Despite its association with age-related diseases, GDF15 has protective effects in various tissues and may act as a mediator of defense processes.

AGEING RESEARCH REVIEWS (2022)

Article Environmental Sciences

Biomarkers of Exposure to Phthalate Mixtures and Adverse Birth Outcomes in a Puerto Rico Birth Cohort

Amber L. Cathey et al.

Summary: This study investigated the association between phthalate metabolite mixtures and pregnancy outcomes using a longitudinal pregnancy cohort in Puerto Rico. The results showed that exposure to phthalate mixtures was associated with increased risk of preterm birth and highlighted the importance of studying mixtures by fetal sex.

ENVIRONMENTAL HEALTH PERSPECTIVES (2022)

Article Geriatrics & Gerontology

Associations Between Elevated Growth Differentiation Factor-15 and Sarcopenia Among Community-dwelling Older Adults

Miji Kim et al.

Summary: This study found that elevated serum GDF-15 levels were associated with prevalent sarcopenia in older adults, but were not able to predict incident sarcopenia over a 2-year follow-up period.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2022)

Article Geriatrics & Gerontology

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients

Chenxi Ren et al.

Summary: The study found that the sarcopenia index based on serum cystatin C and creatinine is associated with long-term mortality, nutritional risk/malnutrition, and sarcopenia in hospitalized older Chinese patients.

CLINICAL INTERVENTIONS IN AGING (2022)

Article Pharmacology & Pharmacy

Molecular routes to sarcopenia and biomarker development: per aspera ad astra

Anna Picca et al.

Summary: Sarcopenia, the age-related decline in muscle mass and strength/function, is a typical geriatric condition. Analyzing tissue biopsies provides valuable insights into its pathophysiology and potential therapeutic targets and biomarkers.

CURRENT OPINION IN PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Prediction of sarcopenia using a battery of circulating biomarkers

Rizwan Qaisar et al.

Summary: The study recruited healthy controls and patients with CHF and COPD, finding several circulating biomarkers effective in diagnosing and assessing sarcopenia. Risk scores calculated from individual biomarkers and combined into a cumulative risk score, with a median cutoff value used to divide subjects into high- and low-risk groups for sarcopenia. The battery of biomarkers can be an effective tool in the early diagnosis and assessment of sarcopenia, with significantly higher incidence of clinical sarcopenia found in the high-risk group.

SCIENTIFIC REPORTS (2021)

Article Geriatrics & Gerontology

Associations between hemoglobin levels and sarcopenia and its components: Results from the I-Lan longitudinal study

Sung-Hua Tseng et al.

Summary: The study found significant associations between hemoglobin levels and sarcopenia and its components, with anemia significantly related to muscle weakness and slowness. The correlation between anemia and sarcopenia was stronger in men and individuals with severe disease burden.

EXPERIMENTAL GERONTOLOGY (2021)

Article Geriatrics & Gerontology

Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults

Richard D. Semba et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)

Article Geriatrics & Gerontology

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

Liang-Kung Chen et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

Article Geriatrics & Gerontology

Nutritional status and body fat mass: Determinants of sarcopenia in community-dwelling older adults

Nasrin Nasimi et al.

EXPERIMENTAL GERONTOLOGY (2019)

Review Multidisciplinary Sciences

Multi-biomarker panel signature as the key to diagnosis of ovarian cancer

Thingreila Muinao et al.

HELIYON (2019)

Article Multidisciplinary Sciences

Prediction of sarcopenia using a combination of multiple serum biomarkers

Ju Yeon Kwak et al.

SCIENTIFIC REPORTS (2018)

Article Geriatrics & Gerontology

Healthy community-living older men differ from women in associations between myostatin levels and skeletal muscle mass

Li-Ning Peng et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)

Review Physiology

GDF15 and Growth Control

Paul J. Emmerson et al.

FRONTIERS IN PHYSIOLOGY (2018)

Article Respiratory System

Multiple biomarkers predict disease severity, progression and mortality in COPD

Rachel L. Zemans et al.

RESPIRATORY RESEARCH (2017)

Review Geriatrics & Gerontology

Sarcopenia: an overview

Emanuele Marzetti et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2017)

Review Geriatrics & Gerontology

Biomarkers in sarcopenia: A multifactorial approach

Francesco Curcio et al.

EXPERIMENTAL GERONTOLOGY (2016)

Article Geriatrics & Gerontology

Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study

Monika Puzianowska-Kuznicka et al.

IMMUNITY & AGEING (2016)

Editorial Material Geriatrics & Gerontology

Welcome to the ICD-10 code for sarcopenia

Stefan D. Anker et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)

Review Biochemistry & Molecular Biology

Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways

J. Rodriguez et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

Article Geriatrics & Gerontology

Simple Biologically Informed Inflammatory Index of Two Serum Cytokines Predicts 10 Year All-Cause Mortality in Older Adults

Ravi Varadhan et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)

Article Geriatrics & Gerontology

Myosteatosis and myofibrosis: Relationship with aging, inflammation and insulin resistance

Elena Zoico et al.

ARCHIVES OF GERONTOLOGY AND GERIATRICS (2013)

Review Rheumatology

Sarcopenia in older adults

Jeremy D. Walston

CURRENT OPINION IN RHEUMATOLOGY (2012)

Article Anthropology

Gender and age differences in lean soft tissue mass and sarcopenia among healthy elderly

Sylvia Kirchengast et al.

ANTHROPOLOGISCHER ANZEIGER (2009)

Article Gastroenterology & Hepatology

Serum alanine aminotransferase in skeletal muscle diseases

RA Nathwani et al.

HEPATOLOGY (2005)

Article Geriatrics & Gerontology

The healthcare costs of sarcopenia in the United States

I Janssen et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)

Review Geriatrics & Gerontology

Sarcopenia: Causes, consequences, and preventions

TJ Marcell

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2003)